Personal information

Other IDs

Scopus Author ID: 57211539242

Activities

Collapse all

Education and qualifications (3)

University of Torino: Torino, IT

2023-11-01 to present | PhD Student in Molecular Medicine (Dipartimento di Biotecnologie Molecolari e Scienze per la Salute)
Qualification
Source: Self-asserted source
Michele Dicataldo

University of Bologna: Bologna, IT

2019-11-01 to 2023-10-31 | Hematology Resident (Istituto di Ematologia «L. & A. Seragnoli»)
Qualification
Source: Self-asserted source
Michele Dicataldo

University of Bari Aldo Moro: Bari, IT

2019-03-19 | Doctor of Medicine
Qualification
Source: Self-asserted source
Michele Dicataldo

Works (15)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia: Results of a Single-Center Study

Hematology Reports
2024-10-17 | Journal article
DOI: 10.3390/hematolrep16040062
Contributors: Davide Stella; Jessica Gill; Roberto Passera; Sofia Zompi; Chiara Maria Dellacasa; Ernesta Audisio; Marco Cerrano; Irene Dogliotti; Michele Dicataldo; Carolina Secreto et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT)

Journal of Clinical Medicine
2023-12-29 | Journal article
DOI: 10.3390/jcm13010208
Contributors: Suzanne Clougher; Marco Severgnini; Antonella Marangoni; Clarissa Consolandi; Tania Camboni; Sara Morselli; Mario Arpinati; Francesca Bonifazi; Michele Dicataldo; Tiziana Lazzarotto et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prognostic Role of CDKN2A Deletion and p53 Expression and Association With MIPIb in Mantle Cell Lymphoma

Clinical Lymphoma Myeloma and Leukemia
2023-08 | Journal article
DOI: 10.1016/j.clml.2023.04.004
Part of ISSN: 2152-2650
Contributors: Francesco Gaudio; Michele Dicataldo; Fabrizia Di Giovanni; Gerardo Cazzato; Antonio d'Amati; Tommasina Perrone; Pierluigi Masciopinto; Filomena Emanuela Laddaga; Pellegrino Musto; Eugenio Maiorano et al.
Source: Self-asserted source
Michele Dicataldo

A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy
2023-05 | Journal article
DOI: 10.1016/j.jtct.2023.02.008
Contributors: Gabriella Chirumbolo; Michele Dicataldo; Martina Barone; Gianluca Storci; Serena De Matteis; Noemi Laprovitera; Barbara Sinigaglia; Francesco Barbato; Enrico Maffini; Michele Cavo et al.
Source: check_circle
Crossref

Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation

Current Opinion in Hematology
2023-01 | Journal article
DOI: 10.1097/moh.0000000000000743
Part of ISSN: 1065-6251
Part of ISSN: 1531-7048
Contributors: Enrico Maffini; Moreno Festuccia; Margherita Ursi; Francesco Barbato; Michele Dicataldo; Marcello Roberto; Elena Campanini; Elisa Dan; Francesco De Felice; Serena De Matteis et al.
Source: Self-asserted source
Michele Dicataldo

Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity

Frontiers in Immunology
2023-01-16 | Journal article
DOI: 10.3389/fimmu.2022.1058126
Part of ISSN: 1664-3224
Contributors: Serena De Matteis; Michele Dicataldo; Beatrice Casadei; Gianluca Storci; Noemi Laprovitera; Mario Arpinati; Enrico Maffini; Pietro Cortelli; Maria Guarino; Francesca Vaglio et al.
Source: Self-asserted source
Michele Dicataldo

Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients

Frontiers in Immunology
2023-01-13 | Journal article
DOI: 10.3389/fimmu.2022.1058739
Part of ISSN: 1664-3224
Contributors: Gianluca Storci; Francesco Barbato; Francesca Ricci; Pier Luigi Tazzari; Serena De Matteis; Enrica Tomassini; Michele Dicataldo; Noemi Laprovitera; Mario Arpinati; Margherita Ursi et al.
Source: Self-asserted source
Michele Dicataldo

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Frontiers in Oncology
2022-11-30 | Journal article
DOI: 10.3389/fonc.2022.1066285
Part of ISSN: 2234-943X
Contributors: Enrico Maffini; Margherita Ursi; Francesco Barbato; Michele Dicataldo; Marcello Roberto; Elena Campanini; Elisa Dan; Francesco De Felice; Serena De Matteis; Gianluca Storci et al.
Source: Self-asserted source
Michele Dicataldo

Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient

Leukemia & Lymphoma
2022-10-15 | Journal article
DOI: 10.1080/10428194.2022.2102622
Part of ISSN: 1042-8194
Part of ISSN: 1029-2403
Contributors: Ginevra Lolli; Margherita Ursi; Michele Dicataldo; Beatrice Casadei; GIANLUCA STORCI; Lisa Argnani; Francesca Bonifazi; PIER LUIGI ZINZANI
Source: Self-asserted source
Michele Dicataldo

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy

Frontiers in Immunology
2022-10-06 | Journal article
DOI: 10.3389/fimmu.2022.994731
Part of ISSN: 1664-3224
Contributors: Serena De Matteis; Beatrice Casadei; Ginevra Lolli; Michele Dicataldo; Francesco Barbato; Elisa Dan; Andrea Paccagnella; Barbara Sinigaglia; Clara Bertuzzi; Annalisa Arcari et al.
Source: Self-asserted source
Michele Dicataldo

Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review

Journal of Neurology
2022-08 | Journal article
DOI: 10.1007/s00415-022-11117-8
Part of ISSN: 0340-5354
Part of ISSN: 1432-1459
Contributors: Umberto Pensato; Lorenzo Muccioli; Pierluigi Zinzani; Roberto D’Angelo; Elisabetta Pierucci; Beatrice Casadei; Michele Dicataldo; Serena De Matteis; Pietro Cortelli; Francesca Bonifazi et al.
Source: Self-asserted source
Michele Dicataldo

Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity

Journal of Neurology
2022-02 | Journal article
DOI: 10.1007/s00415-021-10766-5
Part of ISSN: 0340-5354
Part of ISSN: 1432-1459
Contributors: Umberto Pensato; Giulia Amore; Roberto D’Angelo; Rita Rinaldi; Marianna Nicodemo; Francesca Rondelli; Susanna Mondini; Rossella Santoro; Susanna Sammali; Andrea Farolfi et al.
Source: Self-asserted source
Michele Dicataldo

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience

Cancers
2021-09-24 | Journal article
DOI: 10.3390/cancers13194789
Part of ISSN: 2072-6694
Contributors: Beatrice Casadei; Lisa Argnani; Serafina Guadagnuolo; Cinzia Pellegrini; Vittorio Stefoni; Alessandro Broccoli; Laura Nanni; Alice Morigi; Ginevra Lolli; maria guarino et al.
Source: Self-asserted source
Michele Dicataldo

Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas

Bone Marrow Transplantation
2021-09-09 | Journal article
DOI: 10.1038/s41409-021-01359-x
Contributors: Francesca Bonifazi; Irene Defrancesco; Jacopo Olivieri; Francesco Barbato; Paolo Lopedote; Michele Dicataldo; Mariarosaria Sessa; Elisa Dan; Barbara Sinigaglia; Luca Zazzeroni et al.
Source: check_circle
Crossref

STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas

Leukemia & Lymphoma
2020-02-23 | Journal article
DOI: 10.1080/10428194.2019.1678154
Contributors: Roberto Tamma; Giuseppe Ingravallo; Francesco Gaudio; Tiziana Annese; Francesco Albano; Simona Ruggieri; Michele Dicataldo; Eugenio Maiorano; Giorgina Specchia; Domenico Ribatti
Source: check_circle
Crossref

Peer review (46 reviews for 2 publications/grants)

Review activity for Cancer cell international. (45)
Review activity for Diagnostics. (1)
How many people are using ORCID?